#1 · 068270
Celltrion, Inc.9.43%
Compare KoAct Bio Healthcare Active (462900) holdings, returns, price versus NAV and estimated fund flows. See each data date on the page.
Returns are negative over every period shown. The premium/discount is within 0.5%, so the price tracks NAV closely.
19 of the last 59 sessions (32%) saw net inflows and 23 saw net outflows.
| Date | Estimated net flow |
|---|---|
| 2026-10-14 | — |
| 2026-10-13 | ₩0 |
| 2026-10-12 | +₩1.8B |
| 2026-10-08 | +₩625M |
| 2026-10-07 | +₩2.0B |
| 2026-10-06 | ₩0 |
| 2026-10-02 | ₩0 |
| 2026-10-01 | -₩1.3B |
| 2026-09-30 | +₩621M |
| 2026-09-29 | ₩0 |
| 2026-09-28 | ₩0 |
| 2026-09-23 | ₩0 |
| 2026-09-22 | ₩0 |
| 2026-09-21 | +₩635M |
| 2026-09-18 | +₩638M |
| 2026-09-17 | ₩0 |
| 2026-09-16 | -₩1.9B |
| 2026-09-15 | +₩645M |
| 2026-09-14 | -₩1.3B |
| 2026-09-11 | -₩654M |
| 2026-09-10 | -₩663M |
| 2026-09-09 | ₩0 |
| 2026-09-08 | -₩666M |
| 2026-09-07 | -₩680M |
| 2026-09-04 | ₩0 |
| 2026-09-03 | -₩2.7B |
| 2026-09-02 | +₩1.4B |
| 2026-09-01 | ₩0 |
| 2026-08-31 | +₩1.4B |
| 2026-08-27 | +₩1.5B |
| 2026-08-26 | ₩0 |
| 2026-08-25 | +₩2.2B |
| 2026-08-24 | -₩741M |
| 2026-08-21 | -₩1.4B |
| 2026-08-20 | -₩757M |
| 2026-08-19 | -₩723M |
| 2026-08-18 | +₩1.5B |
| 2026-08-14 | -₩2.3B |
| 2026-08-13 | ₩0 |
| 2026-08-12 | ₩0 |
| 2026-08-11 | +₩2.4B |
| 2026-08-10 | ₩0 |
| 2026-08-07 | +₩738M |
| 2026-08-06 | +₩1.5B |
| 2026-08-05 | +₩1.4B |
| 2026-08-04 | -₩710M |
| 2026-08-03 | -₩1.3B |
| 2026-07-31 | ₩0 |
| 2026-07-30 | -₩1.1B |
| 2026-07-29 | -₩1.2B |
| 2026-07-28 | -₩634M |
| 2026-07-27 | -₩8.0B |
| 2026-07-24 | -₩25.9B |
| 2026-07-23 | +₩1.4B |
| 2026-07-22 | ₩0 |
| 2026-07-21 | -₩1.3B |
| 2026-07-20 | -₩5.9B |
| 2026-07-16 | +₩702M |
| 2026-07-15 | +₩1.4B |
| 2026-07-14 | -₩2.7B |
The top 5 holdings make up 41.4% of the fund, and the top 10 68.8%. New additions as of this snapshot: G2GBIO, Inc.
| # | Holding | Weight | Status |
|---|---|---|---|
| 1 | Celltrion, Inc. 068270 | 9.43% | |
| 2 | Alteogen Inc. 196170 | 8.76% | |
| 3 | OliX Pharmaceuticals, Inc. 226950 | 8.46% | |
| 4 | Hanmi Pharm. Co., Ltd. 128940 | 7.46% | |
| 5 | ST PHARM CO., LTD. 237690 | 7.32% | |
| 6 | ABL Bio Inc. 298380 | 7.20% | |
| 7 | HANALL BIOPHARMA CO.,LTD 009420 | 6.20% | |
| 8 | PharmaResearch Co., Ltd. 214450 | 4.85% | |
| 9 | OSCOTECInc. 039200 | 4.65% | |
| 10 | D&D Pharmatech Inc. 347850 | 4.44% | |
| 11 | GC Biopharma Corp. 006280 | 4.02% | |
| 12 | Rznomics Inc. 476830 | 3.88% | |
| 13 | LigaChem Biosciences Inc. 141080 | 3.61% | |
| 14 | AbClon Inc. 174900 | 3.53% | |
| 15 | Hugel, Inc. 145020 | 3.00% | |
| 16 | Voronoi, Inc. 310210 | 2.60% | |
| 17 | HLB innoVation Co.,Ltd. 024850 | 2.19% | |
| 18 | AprilBio Co.,Ltd. 397030 | 1.91% | |
| 19 | curacle co., ltd. 365270 | 1.78% | |
| 20 | NEXTBIOMEDICAL Co., Ltd. 389650 | 1.62% | |
| 21 | G2GBIO, Inc. 456160 | 1.12% | NEW |
| 22 | KRW Cash 010010 | 0.85% | |
| 23 | SAMSUNG BIOLOGICS CO.,LTD. 207940 | 0.63% | |
| 24 | INGENIA Therapeutics Inc. 950260 | 0.49% |